Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Erin Keller

Ozempic could be coming for a new demographic – your fat cat

The weight-loss drug trend sweeping the nation could be coming for your furry friends.

Okava Pharmaceuticals, a biopharmaceutical company based in San Francisco, is expected to announce on Tuesday that it has launched a pilot study testing a GLP-1 drug in obese cats, the New York Times reports.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.